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A cDNA clone encoding cytochrome P-45011R of rat adrenal has been cloned and sequenced using a bovine P-450 H 
cDNA insert (pcP-450(l 1/?)-2; (1987) J. Bioclfem. 102, 559-568) as a probe. The nucleotide s quence ontains an ope~ 
reading frame sulficient to encode the entire amino acid sequence ofa P-450~ A precursor p otein consisting of499 amino 
acids including an extension peptide of 24 amino acids at the NHz-terminu§. The cDNA contains 1247 nucleotides at
the Y-noncoding region including 51 nucleotides ofpoly A, but lacks the 5'-noncoding region. The deduced amino acid 
sequence shows 61% similarity to that of bovine P-450~1 A" Putative binding sites for heme and steroid are highly conserved 
among steroidogedic P-450s of known structure. 
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1. INTRODUCTION 
Recent studies in our laboratory demonstrated 
that a highly purified preparation of bovine 
adrenocortical cytochrome P-450H, catalyzed not 
only the 118-, 18- and 19-hydroxylations of 
11-deoxycorticosterone but also the conversion of 
corticosterone to 18-hydroxycorticosterone a d 
aldosterone [1-4]. More recently, by subjecting the 
regularly purified preparation of P-45011~ to 
hydroxylapatite HPLC, Ogishima et al. [5] suc- 
cessfully resolved the preparation i to two distinct 
P-450 peaks. Both enzymes were capable of 
catalyzing aldosterone synthesis as well as the 118- 
and 18-hydroxylation of 11-deoxycorticosterone. 
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The sequence data will appear in the EMBL/GenBank/DDBJ 
Nucleotide Sequence Databases under the accession number 
X15431, Cytochrome P-450 11 beta 
The respective NH2-terminal amino acid sequences 
of the two proteins were found to correspond with 
those deduced from the nucleotide sequences of 
two distinct cDNA clones previously reported by 
Kirita et al. [6]. It seems that at least two kinds of 
P-45011~ mRNA are expressed in the adrenal gland 
of the individual animal, and each gene product 
has the oxygenation activity on multiple sites of a 
steroid nucleus. 
In the case of rat adrenal cortex, the existence of 
2 different forms of P-4501m was suggested by us- 
ing another approach. Sodium restriction and 
potassium loading are known to stimulate marked- 
ly the production of aldosterone from cor- 
ticosterone in rats [7]. In 1987 Lauber et al. [8] 
reported the induction of a protein of 49 kDa in 
zona glomerulosa mitochondria of rats on a low 
sodium and high potassium diet. This protein was 
immunocrossreactive with a monoclonal antibody 
raised against purified bovine P-45011fl. On the 
other hand, zonae fasciculata-reticularis mitochon- 
dria prepared from rats maintained on normal diet 
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contained another immunocrossreactive protein of 
51 kDa. According to these authors, the 49 and 51 
kDa proteins were most likely aldosterone synthase 
and the 11B-hydroxylase of rat, respectively [9]. To 
investigate further the property of P-45011a of rat 
adrenal cortex, we have screened a cDNA library of 
rat adrenal gland using a bovine P-45011# cDNA 
fragment as a probe. In this communication we 
describe the isolation and the structural determina- 
tion of a cDNA clone encoding one of rat 
P-45011as. 
2. MATERIALS AND METHODS 
Male Sprague-Dawley rats, weighing 200-250 g, were injected 
intraperitoneally with Cortrosyn (a synthetic ACTH); 0.67 
/zg/animal dally for 3 days. On day 4 animals were killed by 
decapitation a d adrenal glands were dissected out immediately. 
Total RNA was extracted from the glands by the acid guanidium 
thiocyanate-phenol-chloroform (AGPC) method [10]. The po- 
ly(A) ÷ RNA was purified by oligo(dT) column 
chromatography. The mRNA was reverse-transcribed into 
cDNA and the cDNA was fractionated in agarose gel elec- 
trophoresis to obtain DNA species longer than 1 kbp. The 
cDNA was used to construct a library in the bacteriophage ), vec- 
tor, Xgtl0. The library containing independent reeombinants of 
approx. 1.3 × 106 phages was screened using the insert of 
pcP-450(l 1/3)-2 as a probe. Five positively reacting clones con- 
taining long inserts (named 62, 65, 94, 110 and 127) were 
selected and recloned into the EcoRI site of pUC 119 plasmid. 
DNA sequencing was performed by the use of single strand for- 
ward and reverse primers of M13 and Sequenase kit (United 
States Biochemical Corporation). Similarity search among 
amino acid sequences of various P-450s was performed as 
described by Miyata et al. [11]. 
3. RESULTS AND DISCUSSION 
Among the five clones isolated by the plaque 
hybridization method, a clone having the longest 
cDNA insert (pcP-45011B-62) was selected. The 
restriction enzyme map of the insert and the se- 
quencing strategy are illustrated in fig.1. Also 
shown in the figure are the four other independent 
clones, which are found to have the nucleotide se- 
quences identical to that of pcP-45011B-62 up to 
about 200 bp. One of the clones (110) begins from 
the same position as pcpo45011B-62. 
Fig.2 shows the complete nucleotide sequence of 
pcP-45011B-62. The overall length of the cDNA 
was 2747 bp including the poly(A) tail and is in 
good agreement with the mRNA size estimated by 
the Northern hybridization (2.7 kb, not shown). 
The open reading frame begins from the first 
"110 
127 
~94 
~65 
' " ' ,'--'T-"-- 
. : _ .  ", ~ • , ~.~ 
0 05 ~0 ~5 2.0 25 275 
(kbp) 
Fig.l. Restriction enzyme map and sequencing strategy for the 
P-450Ha cDNA clone. Rectangular box shows the cDNA insert 
of pcP-45011/3-62. The open box represents the extension- 
peptide, the closed box, the mature protein and the line, the 
3'-noncoding region. Horizontal arrows in the lower space in- 
dicate the direction and extent of sequencing. Arrows with 
numbers in the upper space indicate the extent of sequencing of
the other independent clones (65, 94, 110 and 127). 
nucleotide 'A' at the 5' terminus, and codes for a 
peptide consisting of 499 amino acids. Evidence 
that the peptide is that of rat cytochrome P-45011a 
is provided by striking sequence similarity between 
the amino acid sequence deduced and those of 
bovine, mouse, and human P-45011~s. The cDNA 
of rat P-45011a has a long (1247 bp) noncoding 
region at the 3'-terminus. 
As shown in fig.3, the predicted amino acid se- 
quence at the NH2-terminus i considerably similar 
to those of the bovine [6,12,13] and mouse [14] en- 
zymes. It should be noted that the nucleotide se- 
quences of coding regions of the rat and mouse 
cDNAs are identical in the first 78 nucleotides 
(residue 8 of the mouse enzyme, Val, should be 
Asp, when translated from the nucleotide sequence 
described in [14]). The Met codon at the 5' ter- 
minus of the rat cDNA is thought o be the initia- 
tion codon, because the corresponding Met codons 
of the bovine and mouse enzymes have been iden- 
tified as the true initiation codons by the use of SI 
nuclease analysis [12,14]. Since the cleavage site of 
bovine P-45011~ precursor peptide is Leu24-Gly25, 
that of the rat peptide is most likely at the same 
position. These considerations uggest that the 
extension-peptide of rat P-450Ha precursor cor- 
responds to a peptide of the NH2-terminal 24 
amino acid residues (2864 Da). It is interesting to 
note that the predicted extension-peptide is strong- 
ly basic in that it has 4 Arg and 1 His residues, 
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ATG GCT 
Met Ala 
GCC CCC 
Ala Pro 
CAA GAG 
Gin Glu 
GTG ATG 
Val Net  
GAA CTC 
GIU Leu 
CCA AAA 
Pro Lys 
CAT GGA 
His Gly  
CTC ACA 
Leu Thr 
CCC AAG 
Pro  LyS 
ATC AAG 
l i e  Lys 
GAT GCC 
Asp Ala 
CGG AAC 
Arg ASh 
CTG CCC 
Leu Pro 
CTT CAG 
Leu Gin 
CGC TAC 
Ar¢ Tyr 
CTC AGG GTG ACA GCA GAT GTG TGG CTG GCA AGA CCC TGG 
Leu Arg Val Thr Ala Asp Val Trp Leu Ala Arg Pro Trp 
AAG ACA CTG /tAG CCC TIT GAA GCC ATA CCA CAA TAC TCC 
Lys Thr Leu Lys Pro Phe Glu A1a I le  Pro Gln Tyr Ser  
AAC CTA CAC CTG GAG ATG CAC CAG GCC TTC CAA GAG CTG 
Asn Leu 
CTG CCT 
Leu Pro  
CGT GGC 
ArK Gly 
GCC ATT 
Ala I I e  
AGC ATG 
Ser Met 
GGC CAT 
Gly I l ls  
AGC ']q'G 
Ser Leu  
AAT GTG 
ASh Val 
ATC CAT 
I l e  HIS 
CCA GAT 
Pro Asp 
TTG CTG 
Leu  Leu 
AAC TAT 
ASh Tyr 
ATG CCT 
Met Pro  
His Leu Glu Met Hls Gin Ala Phe Gin Glu Leu 
GAG GAC GCT GAG AAG CTG CAG CAG GTG GAG AGT 
Glu ASp Ala GIu Lys Leu His Gin Val Glu Ser  
CTG AGA CGT GGT GTG TTC TTG CTA AAT GGG GCA 
Leu  Arg Arg Gly Val Phe Leu Leu Ash Gly Ala 
CAA TCT TTT GTC CCC TTT GTG CAT GTG GTA GCA 
Gln Ser  Phe Val Pro Phe Val ASp Val Val Ala 
TCT ATA AAC ATT CAG TCC AAT ATG TTC AAC TAT 
Set lle Asn lle Gin Set Asn Met PBe Asn Tyr 
GAC CTG AAACCT GAG AGC GTG ACA TTC ACT CAT 
Asp Leu Lys Pro Glu Ser Val Thr Phe Thr Ills 
ACT CGT TGG ACA AGC ACC CGG GTG TGG AAA GAA 
Thr ArK Trp Thr Ser  Thr Ar¢ Val Trp Lys Glu 
TAT CGC GAA CTG GCA GAG GGT CGC CAA CAG TCC 
Tyr ArK GIu Leu Ala Glu Gly Arg Gin Gln Ser 
GCC AAC TCA ATG GAA CTT A~i~ GCT GGA AGT GTT 
Ala ASh Ser Met Glu Leu lle Ala Gly Ser Val 
GTT CAG CAG GCC CTG CGG CAG GAG AGC CTA GCA 
Val Gln Gin Ala Leu Arg Gln Glu Ser Leu Ala 
CGG GCT GCC CTT AAA GAG ACC TTG AGG CTC TAC 
Arff Ala Ala Leu Lys GIU Thr Leu Arg Leu Tyr  
CAT GTC CCT GCT GGG ACA TTC GTC ATA ATT "FAT 
His Val Pro Ala Gly Thr Phe Val l i e  [le Tyr  
CAG CGC TGG CTG GAG AC~ AAA AGG AGT TTC CAG 
Gln Arg Trp Leu Glu ArK Lys ArK Ser Pho Gln 
CTG GCA GAG GTG GAG ATG G÷G CTC CTG CTT CAG CAT ATG CTG AAA 
Leu Ala Glu Val Glu Met Leu Leu Leu Leu His Hls Met Leu Lys 
CAG TGC 
Gin Cys 
AGG MtC 
Arg Asn 
GGG CCC 
GIy Pro 
ATC CTC 
l ie  Leu  
GAC TGG 
Asp Trp 
AGG GAC 
Ar8  Asp 
ACC ATG 
Thr Met 
GCT CTG 
AIa Leu  
CAC TTT 
His  Phe 
TGG AGT 
Trp Ser 
GAC ACG 
Asp Thr 
GCT GAG 
Ala  GIU 
CCT GTT 
Pro Val 
CTG T~C 
Leu Tyr 
CAT C+G 
HIs Leu 
ACC TTC 
Thr Phe 
CTG CAC AGG 
Leu His Arff 
AAG TGG CTG 
Lys Trp Leu 
ATTTTC AGG 
I I e  Phe Ar¢ 
CCG CAT CGG 
Pro  HIs Arg 
CGC TTC AAC 
Arc  Phe Asn 
TTT GTG GAP. 
Phe Val GIu 
GAA GCC AGC 
GIu Ala Ser 
CAC TCA ATG 
HIs  5er  Met 
CAT TCC TGG 
ASp Ser T rp  
GTC ATA TCC 
Val Ile Ser 
ACA GCA ATC 
Thr Ala I Ie  
GCC AGC ATC 
Ala Ser ne  
GGT AGC TTT 
Gly Ser Phe 
TCC ATG GGC 
Set  Net Gly  
GCC TTC GGC 
Ala Phe Gly  
GAA GTG GAG 
Gin Val GIu 
ACG AGG GCA 
Thr Arg Ala 
AAG ATG ATA 
Lys Met I Ie  
CAC AGT GCA 
His  Set  Als  
ATG CCC CTG 
Met Pro Leu 
CGA CTG CAG 
ArK Leu Gin 
AAC CTG AAG 
ASh Leu Lys 
CAT TTT GTT 
H|S Phe Val 
TTC AAG TCC 
Phe Lys Set  
GAT ATC ATC 
Asp l l e  l i e  
GAG ATG GTA 
GIu Met Val 
TCC TTG GTA 
Ser Leu VaJ 
GTT GCT AAT 
Val Ala Asn 
GTA GAG AGA 
Val GIu Arg 
CGA AAC CCT 
Arff  ASh Pro  
TTT GGG GTG 
Phe GIy  Val 
ACA CTG AGA 
Thr  Leu Ar¢  
CTG~GGC ACT ACG GCA AAA GTC 
Leu G Iy  Thr  Thr  A la  Lys  Va l  
CAG ATC CTG AGA GAG CAG GGC 
G ln  I le  Leu Arc  GIu G in  Gly 
GGG GGA GCA CAG ATT GTG TCT 
G ly  G ly  A la  G ln  I le  Va l  Set  
GAG CCG TGG GTG GCC CAC AGA 
GlU Pro Trp Val Ala His Ar t  
CTG AAT CCA AAT &TG CTG TCA 
Leu Asn Pro  Asn Met Leu Set  
AAG AGA ATG CTG GAG AAT GTT 
Lys  Arg  Met Leu G lu  Asn Va l  
ATT TCC GGA GAG CGT CTG GGC 
I le  Ser  G ly  G lu  Arg  Leu GIy 
ACC ACA CAG CTC ATG TTC TTA 
Thr  Thr  G ln  Leu Met Phe Leu 
TCT GAG TAT GTC ACA AAA TGT 
Set Glu Tyr Val Thr Lys Cys 
GCA CAG AGT ACT CTG TCA ATG 
Ala Gin Ser Thr Leu Ser Met 
ATG ACC CTT TTT GAG CTG GCT 
Me~ Thr  Leu Phe  Glu  Leu Ala 
CCC CAG AAG GCC ATG TCA GAC 
Pro  G in  Lys A la  Met Ser Asp 
ATC GTA CAC TCA GAC CTG GTG 
lle Val His Ser ASp Leu Val 
~c  ^GTG "rrc cfiA AG~ CCT C^ ~ 
Ala Va l  Phe Pro  Arg Pro  GIu 
~Qc CAG TGC c÷G G~ eGG CG~ 
Arg Gin Cys Leu GIy Arg Arg 
CAA GAG CAT ATG CAG ATG GTT 
Gin Glu ASp Met Gln Met Val 
90 
180 
270 
360 
450 
540 
630 
720 
810 
0G0 
090 
1080 
1170 
1260 
1350 
1440 
TTT CGC TTT cTr  TTG ATG CCC AGC TCT AGT CCTTTC CTT ACT TTC CGG CCT GTG AGC TAG 1500 
Phe Arg  Phe Leu Leu Net  Pro  Set  Ser  Ser  P ro  Phe Leu Thr  Phe Arg  Pro  Va l  Ser  . . -  
TCACCTTAC~TCTGGGGCCCTAGTCAGTCCACCACC~TACCTCTGTCCTGACACCCAAGGTCACACTTCTCTGCCAGC~GAA~llr~GTGGGAGGAGGTCACACTGTCATCATTCAACA 1620 
CAACTGTACAC£GTTTAcAGeTGAAGACcT~CAGCATCAC'GTACAAGCA~C~CCAgGGAAgAGA~AGGACTATcTTCAGGGCAATAGGTAGTCTcTcCTGAGCGGTCTTCCCCATTCTT 1740 
TcC~CGGTcAcTcCAGGTGGccACGGCcTTTAAAGGGTCTcAGAGTAAAGccAg~GTCAAcTCCTccTTATGTcCTCATTATTATGACATGAcccACAAAAAcATTrTCACACACAGA 1860 
TGGGAATTTTT~GGCAAAAGATACATAGATGATAGATAGATATATGATATATTACATATATGATAGATGATAGATAGATAGATGATAGATAGATAGATAGATAGATAGATAGATAGATAG 1980 
ATAGATAGATAGATAGATGATGGATGACCAGTCA1~TA~TCTGTG1~`TGTTTGAAGCCT.I.rCACAGTGGAGCTGGCACATACGAGCTGGTGAG~CTACAGTGFr~T~AGAGTAGACAC 2100 
AGCTGCAC~rTGCT~AGGACTGGGTGG]TGTGGTATCAGAGATGCAGGCAGGAGGACCTGCTGGAACCCAGATACTGTGTGAAGTCCCCACAGGGACAGTGGTC~CCATGAGGTCA^GGT 2220 
G"UI'TCCTGACI~rCTG CCAGTGCATGGTGCTTGGGC A/LAGGTAATTCTC TTGACTTGTGAAAGTG C CCAGATCATAAGAITI- ITI~AGGTCTCCTTTCAGCTGCAAGTCGGTAGGGC AA 2340 
AA GTI'I'FGGC  AAGAACAA C CACTTCA CAGGGTCTC TGTGCTC AGCACTAAAGCACAAATCTACTGGAGATGTGTGTGCCAAG'UFCCAAGGTCTTAGA CCTTTGAGTGTGAGGCA GTAT 2460 
AGAGTCGGGC~CCTTTAATGATATAATTCGTGTGAAATGAGATTACTGGGTTGTGCCTACTCCAGTGCCCAGAGAGCCTCCGAAGAAGAGAGTGAGGTGCCAGGTCACAGAGAGAGACCCA 2580 
AGTGGAAGACAGGAAGTCAGACTTCTGTAAGTGGAGGAAAGCAGTTGGAACTCCTACAGTCTTGGCTCCATCACTCAATCACTTCCcTGGCTGTGAAA~A'TA~`~jJt'~'~'~CTTGAGTTGTTG{A)51 
Fig.2. Nucleotide sequence of the P-450~la eDNA clone and the deduced amino acid sequence. The cleavage site by processing protease 
is indicated by an arrow. The underlined sequence within 3'-noncoding region indicates a polyadenylation signal. 
though it has 1 Asp residue at the 8th position. 
These characteristics are compatible with the 
feature of the extension-peptides of mitochondrial 
precursor [15]. 
The entire amino acid sequence of rat P-450~a is 
similar to those of the bovine (61%), mouse and 
human enzymes. When the sequences of rat, 
bovine and human enzymes are aligned with one 
another, deletions are found at two portions, that 
is, around the 290th and the 433rd residues, and in- 
sertion is found around the 299th residue (the 
numbers correspond to those of the rat enzyme). 
These portions of  the peptides may not play impor- 
tant roles in the enzymatic function or the 
maintenance of the three-dimensional structure of 
the enzyme. 
A comparison of the sequences of  rat and bovine 
P-45011~s with those of the other steroidogenic 
P-450s, such as P-450scc [15], P-450c21 [16] and 
P-45017~ [17], shows that there are two highly iden- 
tical regions. The first region is the heme binding 
site as depicted as a box marked with two asterisks 
in fig.3. Cys446 is thought to serve as the fifth 
ligand to heme. The sequence around it reveals a 
common feature of the heine-binding site of P-450, 
that is, F-X-X-G-X-R-X-C-X-G-X-X-X-A [18]. 
Also conserved among rat, bovine and human 
P-450H~s is Glu453 (next to Ala in the above- 
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! 
rat MALRVTADVW LARPWQCLHR TRA~GTTAKV APKTLKPFEA IPQYSRNKWL 
bov ine  - - -WAK-R-R  M-G- -LS - -E  A -L - - -RGA . . . .  AVL . . . .  M-RCPG- - -M 
mouse  . . . . . . .  V . . . . . . . . . . . . . . . . . . . .  TL . . . . .  Q . . . . . .  
50 
50 
42 
rat KMIQ ILREQG QENLHLEMHQ AFQELGPIFR HSAGGAQIVS VMLPEDAEKL  i00 
bovine R-L - -WK- - -  S - -M- -D- - -  T . . . . . . . . .  YDV- -RHM-F  . . . . . .  V-R- i00 
rat HQVESILPHR MPLEPWVAHR ELRGLRRGVF LLNGADWRFN RLQLNPNMLS 150 
bovine Q-AD-RH-Q-  -I .... L-Y- QA- -HKC . . . . . . .  PQ- -LD - -R- - -DV- -  150 
ra t  PKAIQSFVPF VDWARDFVE NLKKRMLENV HGSMSINIQS NMFNYTMEAS 200 
bov ine  LP -L -KYT-L  - -G  . . . . .  SQ T - -A -V -Q-A  R- -LTLD-AP  SV-R- - I - - -  200  
ra t  HFVISGERLG LTGHDLKPES VTFTHALHSM FKSTTQLMFL PKSLTRWTST 250 
bov ine  TL -LY  . . . . . .  LTQQPN-D-  LN- I - - -EA-  L - - -V  . . . .  V -RR-S - -M- -  250  
human WffiAEAffiSSA . . . .  L - -M=V . . . . . . . . . .  M . . . . . . . . .  P 
rat RVWKEHFDSW DI ISEYVTKC IKNVYRELAE GRQQSWSVIS  *E**MVAQSTLSM 300 
bov ine  NM-R- - -EA-  -Y -FQ-ANRA -QRI -Q- - -L  -HPWHY-G-V A -LL -R -DM- - f t  301  
human K . . . . . . . . . .  C . . . .  GDN- -=K . . . . . .  N S -=-QfTS  . . . . . .  LN-ELSPto  
rat DA IHANSMEL IAGSVDTTAI  SLVMTLFELA RNPDVQQALR QESLAAEASI  350 
bov ine  -T -K - -T ID-  T . . . . . . . .  F P -L  . . . . . . . . . .  E . . . .  V . . . . .  V - - -R -  351 
human . . . . . .  C . . . . . . . . .  R-V . . . . . . . . . . . . . .  N . . . . . . . . . . . .  A- - -  
ra t  VANPQKAMSD LPLLRAALKE TLRLYP~GSF VERIVHSDLV LQNYHVPAGT 400 
bov ine  SE- - -R - ITE  . . . . . . . . . . . . . . . . . . .  / I T  L - -E -S  . . . . . . . . .  I . . . .  401  
human ==H . . . .  T . . . . . . . . . . . . . . . . .  - ] - - L I  =- -V  . . . . . . . . . . . . . . .  
ra t  FVI IYLYSMG RNPAVFPRPE RYMPQRWLER KRS- - ,FQHL~FG FGVRQCLGRR 450 
bov ine  L -KVL- - -L  . . . . . . .  A - - -  S -H  . . . . .  D- QG-GSR-P - - -~  . . . . . . . . . . .  454  
/ 
human =-RffiF . . . . . . . . .  L . . . . . . .  N . . . . . .  I . . . .  RN-Y -VP~-  - -M . . . . . . .  
ra t  
bov ine  
human 
LAEVEMLL_~_ HHMLKTFQVE TLRQEDMQMV FRFLLMPSSS PFLTFRPVS 499 
Y- - I  . . . .  TL -LF - - -A IQ  503  
Fig.3. Compar ison  of  the amino  acid sequence of  rat P-45011~ with those of  bovine, mouse and human enzymes. The sequences of  
bovine, mouse and human P-4501ta were taken f rom [6,14,13] respectively. The peptides enclosed with boxes with one and two asterisks 
indicate the putat ive heme/stero id  binding site and the heme binding site, respectively. ( - ) and ( = ) indicate that the amino  acid is iden- 
tical to that of  rat enzyme and to that of  bovine enzyme, respectively. The cleavage site by processing protease is depicted by arrowhead.  
mentioned peptide), which has been pointed out as 
a feature of mitochondrial type P-450s by 
Morohashi et al. [12]. 
Another region that is identical among the 
steroidogenic P-450s is found in a stretch spanning 
residues 361-376 (shown as a box marked with an 
asterisk in fig.3). Fig.4 illustrates the amino acid se- 
quences of this region found in steroidogenic 
P-450s. Glu370 and Arg373 (indicated with 
asterisks) are conserved in all the P-450s whose 
structures have been so far determined [19,20]. 
Among the P-450s of known structure, a sequence, 
L(364)-X-A-X-X-X-E-X-L-R-X-X-P, is found on- 
ly among steroidogenic P-450s, such as P-4501~, 
P-450scc, P-450c21 and P-45017~. 
A comparison of the amino acid sequence of 
P-450em [19] with that of rat P-450H0 indicates the 
presence of the sequence, E-X-X-R, at the 
288-291st of P-450cam. This region resides in helix 
K (the peptide stretch of the 280-292nd amino acid 
residues) [21 ]. In the three-dimensional structure of 
P-450cam, the helix constitutes a part of heme 
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Spec ies  No. 
RAT P -45011B 361 
Bov ine  P -45011 ~ 362 
Bov ine  P-450SC C 373 
Human P-450SC C 374 
Bov ine  P -450C21 341 
Mouse P -450C21 334 
Porc ine  P -450C21 341 
Human P -450C21 343 
Human P -45017 a 350 
Bov ine  P -45017 a 350 
Ch icken  P -45017 a 353 
LPLLR 
~ PLLR 
PLLK  
PLLK  
PLLN 
PLLM 
PLLN 
PLLN 
IV~LIEI 
A A 
Sequence  
A-A L K 'E  
AALKE 
AS  I K:E i 
AS I KiE 
AT IAE  
AT IAE  
AT IAE  
AT  I AE  
A]T I RE  
~] T I RE  T I  SE  
TLRL  
TLRL  
TLRL  
TLRL  
VLRL  
VLRL  
VLRL  
VLRL  
VLRL  
VLR V 
GLR~ 
A ~ 
YP ° 
YP  G 
HP IS  
HP IS  
RPV IV  
RPVV 
RPVV 
RPVV 
RPVA 
RPVA 
R S 
A 
Fig.4. Amino acid sequences of a conserved region in steroidogenic P-450s. The amino acid sequences of a region highly conserved 
among steroidogenic P-450s are shown. The numbers are those of the amino acid residues depicted as the first in the peptides. Amino 
acid residues conserved inmore than 9 P-450s are enclosed. Asterisks and arrowheads indicate the conserved amino acids among all 
the P-450s of known structure and those among steroidogenic P-450s, respectively. The amino acid sequences of bovine P-45011a, bovine 
and human P-450sccs, porcine P-450C2L, and chicken P-450~7,~ were taken from [6, 15, 22, 23] respectively. The other sequences were 
found in [19]. 
pocket, and an amino acid residue located in the 
vicinity of this helix, Va1295, directly interacts with 
the substrate (camphor) or the inhibitor 
(metyrapone). Va1295 in P-450cam corresponds to 
Va1377 in P-45011~, which is the amino acid residue 
next to Pro376 in the above-mentioned consensus 
sequence. Taking these points into consideration, 
we propose that the peptide stretch from Leu364 to 
Pro376 and the following region constitute a part 
of the heme- and steroid-binding sites of P-450Zl~. 
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